Delafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Public ClinicalTrials.gov record NCT01811732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study was designed to evaluate the efficacy of delafloxacin patients with acute bacterial skin and soft tissue infections (ABSSSI).
Study identification
- NCT ID
- NCT01811732
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 660 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2013 (Actual)
- Primary completion
- Jul 2014 (Actual)
- Completion
- Jul 2014 (Actual)
- Last update posted
- Sep 27, 2017
2013 – 2014
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Melinta Investigational Site | Montgomery | Alabama | 36106 | — |
| Melinta Investigational Site | Anaheim | California | 92804 | — |
| Melinta Investigational Site | Chula Vista | California | 91911 | — |
| Melinta Investigational Site | La Mesa | California | 91942 | — |
| Melinta Investigational Site | Long Beach | California | 90813 | — |
| Melinta Investigational Site | Los Angeles | California | 90015 | — |
| Melinta Investigational Site | Modesto | California | 95350 | — |
| Melinta Investigational Site | Oceanside | California | 92056 | — |
| Melinta Investigational Site | Pasadena | California | 91105 | — |
| Melinta Investigational Site | Stockton | California | 95204 | — |
| Melinta Investigational Site | Miramar | Florida | 33027 | — |
| Melinta Investigational Site | Minneapolis | Minnesota | 55422 | — |
| Melinta Investigational Site | Butte | Montana | 59701 | — |
| Melinta Investigational Site | Las Vegas | Nevada | 89109 | — |
| Melinta Investigational Site | Somers Point | New Jersey | 08244 | — |
| Melinta Investigational Site | Smyrna | Tennessee | 37167 | — |
| Melinta Investigational Site | Richmond | Texas | 77469 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01811732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2017 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01811732 live on ClinicalTrials.gov.